Use of topical 2.4% glycopyrronium tosylate in familial benign pemphigus (Hailey-Hailey disease)

Dermatol Online J. 2020 Oct 15;26(10):13030/qt01j7n9qw.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Topical
  • Cholinergic Antagonists / administration & dosage*
  • Cholinergic Antagonists / adverse effects
  • Constipation / chemically induced
  • Drug Administration Schedule
  • Glycopyrrolate / administration & dosage*
  • Glycopyrrolate / adverse effects
  • Humans
  • Male
  • Middle Aged
  • Pemphigus, Benign Familial / drug therapy*
  • Pemphigus, Benign Familial / pathology
  • Scrotum / pathology
  • Xerostomia / chemically induced

Substances

  • Cholinergic Antagonists
  • glycopyrronium tosylate
  • Glycopyrrolate